Image Description (Structure)
Losartan Potassium
Product Images NDC 61919-030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 61919-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Warning)
The text is a warning message stating that the use of losartan potassium tablets is harmful to the fetus during pregnancy. It is advised to discontinue the use of the medication as soon as possible when pregnancy is detected. The use of drugs that affect the renin-angiotensin system during pregnancy can lead to fetal toxicity and even death. The full details can be found under the warnings section.*
030 (Losartan030)
The text seems to be a list of medication and their dosages. It includes medication names such as LISATIAN POTASSIUM and LOSARTAN POTASSIUM with their corresponding dosage of 50mg and 30 Tabs. It also includes a warning label of "RX ONLY-KEEP OUT OF REACH OF CHILDREN." However, the text is not conveniently readable due to errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
